2 recruiting, 1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Hyperthyroxinemia: new trials by email Literature Review of Hyperthyroxinemia trials Research Report on Hyperthyroxinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects NGS sequencing, serological tests - Resistance, Thyroid Hormone | Recruiting | Istituto Auxologico Italiano | 150 | 2023-01-01 | 2025-09-02 | |
| A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) Resmetirom - Non-Alcoholic Fatty Liver Disease | Phase 3 | Active not recruiting | Madrigal Pharmaceuticals, Inc. | 810 | 2021-07-09 | 2026-05-27 |
| Register for Patients With Thyroid Hormone Resistance. no intervention - Hypothyroidism, Global Developmental Delay | Recruiting | Charite University, Berlin, Germany | 200 | 2021-07-01 | 2024-08-22 | |
| A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients Placebo, Resmetirom - Non-Alcoholic Fatty Liver Disease | Phase 3 | Completed | Madrigal Pharmaceuticals, Inc. | 1343 | 2019-12-16 | 2023-09-05 |
Thyroid Hormone Resistance Syndrome (4) · Dyslipidemias (2) · Fibrosis (2) · Hyperlipidemias (2) · Non-alcoholic Fatty Liver Disease (2) · Allan-Herndon-Dudley syndrome (1) · Dystonia (1) · Hypothyroidism (1) · Intellectual Disability (1) · Learning Disabilities (1) · Microcephaly (1) · Muscle Hypotonia (1) · Seizures (1)
Endocrine System Diseases (4) · Thyroid Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Digestive System Diseases (2) · Fatty Liver (2) · Lipid Metabolism Disorders (2) · Liver Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Communication Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1)
resmetirom (2) · Serologic Tests (1)
Madrigal Pharmaceuticals, Inc. (2) · Charite University, Berlin, Germany (1) · Istituto Auxologico Italiano (1)
Puerto Rico (2) · United States (2) · Germany (1) · Italy (1)
Heiko Krude, MD (1) · Rebecca Taub, MD (1) · Tom Hare, MD (1)
PMID 37786277, PMID 34969638, PMID 37845512, PMID 37881807, PMID 41142528, PMID 41953252